ADSCs-Exos inhibit renal fibrosis by regulating apoptosis and fibrosis-related cell proliferation, reducing the severity of CKD, and restoring renal function by increasing the levels of aquaporins 2 and 5. This evidence concerns the gene AQP2 and renal fibrosis.